A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer

Local Institution - 0003, Westmead

Local Institution - 0001, Malvern

Local Institution - 0050, Liège

Local Institution - 0023, Greenslopes

Local Institution - 0051, Charleroi

Local Institution - 0004, Murdoch

Local Institution - 0034, Ghent

Local Institution - 0036, Athens

Local Institution - 0029, Rozzano

Local Institution - 0002, Durham

Local Institution - 0021, Madrid

Local Institution - 0005, Majadahonda

Local Institution - 0006, Málaga

Local Institution - 0075, Birmingham

Local Institution - 0030, Peschiera del Garda

Local Institution - 0081, Nashville

Local Institution - 0060, Cincinnati

Local Institution, Cincinnati

Local Institution - 0031, Pisa

Local Institution, Dallas

Local Institution - 0041, Craiova

Local Institution - 0042, Cluj-Napoca

Local Institution - 0069, Takatsuki

Local Institution - 0022, Hackensack

Local Institution - 0067, Cleveland

Local Institution - 0012, Edmonton

Local Institution - 0064, Brampton

Local Institution - 0045, Heraklion

Local Institution - 0038, Athens

Local Institution - 0073, Sendai

Local Institution - 0070, Ōsaka-sayama

Local Institution - 0077, Ina-machi

Local Institution - 0039, Amsterdam

Local Institution - 0066, Arnhem

Local Institution - 0040, Groningen

Local Institution - 0049, Gdansk

Local Institution - 0048, Lodz

Local Institution - 0043, Bucharest

Local Institution - 0007, Barcelona